Thailand FDA Recalls Hong Thai Inhalers Over Contamination

Thailand's Food and Drug Administration found microbial contamination in Hong Thai Herbal Inhaler Formula 2 batch 000332 (produced Dec. 9, 2024; expiry Dec. 8, 2027) and has recalled about 200,000 units. Laboratory tests showed excessive total aerobic microbial counts, high combined yeasts and mould counts, and the presence of Clostridium bacteria including C. perfringens, prompting warnings that inhaling contaminated products can cause respiratory and other infections, especially in the elderly and immunocompromised. The FDA has suspended manufacture of the affected products, ordered recall and destruction of the batch, said it may pursue legal action, and is testing other brands with samples from Chama Herbs also flagged. Manufacturer Thai Herbal Hong Thai Ltd. acknowledged the findings, is coordinating the recall and destruction, is offering full refunds to retailers and customers, and says it has strengthened production and quality-control measures. Authorities urged consumers to stop using the affected batch, check packaging for batch 000332, and warned that the pocket “yadom” inhalers are sold nationwide and widely used by locals and visitors.